MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11033-026-12216-9

Медицинская библиотека · Molecular biology reports · 2026

Overcoming resistance in glioblastoma immunotherapy: lessons from the past and opportunities for the future.

Lahariya Rijhul, Sinha Mainak

СтатьяОбзорПеревод в очереди

Аннотация

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, characterized by rapid proliferation, diffuse invasion, and profound therapeutic resistance, leading to a median survival of approximately 15 months despite maximal treatment. Immunotherapy, which has transformed outcomes in other malignancies, has shown limited success in GBM due to its immune-privileged environment, extensive immunosuppressive networks, and tumor heterogeneity. Clinical trials of checkpoint inhibitors, cancer vaccines, CAR-T cells, oncolytic viruses, and microenvironment-targeting agents have largely failed to produce durable survival benefits, often hindered by poor T-cell infiltration, antigen loss, and redundant suppressive mechanisms within the tumor microenvironment. Lessons from these failures highlight the necessity of mechanism-informed strategies that address the tumor's immune evasion. Next-generation approaches emphasize priming the tumor to enhance immune visibility, targeting multiple antigens to prevent escape, optimizing locoregional CAR-T delivery, using oncolytic viruses as immune catalysts rather than sole cytotoxic agents, and strategically modulating the microenvironment to support effector responses. By integrating these insights, rational combination strategies can transform GBM immunotherapy from incremental efficacy to meaningful clinical benefit. Translational rigor, adaptive trial designs, and biology-driven interventions are essential to overcoming the complex barriers posed by GBM and achieving durable anti-tumor immunity.

Для цитирования: Lahariya Rijhul, Sinha Mainak. Overcoming resistance in glioblastoma immunotherapy: lessons from the past and opportunities for the future.. Molecular biology reports. 2026. DOI: 10.1007/s11033-026-12216-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.